Marcin Braun
Overview
Explore the profile of Marcin Braun including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
708
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Gorska-Arcisz M, Popeda M, Braun M, Piasecka D, Nowak J, Kitowska K, et al.
Cell Mol Biol Lett
. 2024 May;
29(1):71.
PMID: 38745155
Background: Genetic abnormalities in the FGFR signalling occur in 40% of breast cancer (BCa) patients resistant to anti-ER therapy, which emphasizes the potential of FGFR-targeting strategies. Recent findings indicate that...
12.
Szmyd B, Stanislawska P, Podstawka M, Zaczkowski K, Izbinski P, Kulczycka-Wojdala D, et al.
Int J Mol Sci
. 2024 Apr;
25(8).
PMID: 38673919
Glioblastoma, a highly aggressive brain tumor, poses significant treatment challenges. A deeper investigation into its molecular complexity is essential for the identification of novel prognostic biomarkers and therapeutic strategies, potentially...
13.
Braun M, Piasecka D, Sadej R, Romanska H
Br J Cancer
. 2024 Apr;
131(1):11-22.
PMID: 38627607
Breast cancer (BCa) is a complex and heterogeneous disease, with different intrinsic molecular subtypes that have distinct clinical outcomes and responses to therapy. Although intrinsic subtyping provides guidance for treatment...
14.
Robak T, Braun M, Guminska A, Iskierka-Jazdzewska E, Robak P
Leuk Lymphoma
. 2024 Apr;
65(8):1175-1180.
PMID: 38608253
No abstract available.
15.
Tomasik B, Garbicz F, Braun M, Bienkowski M, Jassem J
Camb Prism Precis Med
. 2024 Mar;
2:e2.
PMID: 38549846
Precision oncology is a rapidly evolving concept that holds great promise in cancer treatment. However, a cancer complexity attributed to genomic and acquired tumour heterogeneity limits treatment effectiveness and increases...
16.
Robak E, Braun M, Robak T
Cancers (Basel)
. 2023 Nov;
15(22).
PMID: 38001655
Leukemia cutis (LC) is defined as the leukemic infiltration of the epidermis, the dermis, and the subcutaneous tissue. Leukemia cutis may follow or occur simultaneously with the diagnosis of systemic...
17.
Salifu M, Bets I, Gdula A, Braun M, Watala C, Beckles D, et al.
J Vasc Interv Radiol
. 2023 Oct;
35(2):285-292.
PMID: 37871832
Purpose: To determine whether inhibition of the F11 receptor/JAM-A (F11R) using F11R-specific antagonist peptide 4D results in inhibition of smooth muscle cell (SMC) proliferation and migration in vivo, known as...
18.
Slawinski L, Solek J, Milkowska-Dymanowska J, Jesionek-Kupnicka D, Gora-Tybor J, Mikulski D, et al.
Contemp Oncol (Pozn)
. 2023 Oct;
27(2):113-117.
PMID: 37794994
Primary pulmonary Hodgkin's lymphoma (PPHL) is a rare subtype of lymphoma that comprises a small percentage of primary pulmonary lymphomas. Due to its rarity and nonspecific symptoms, PPHL often presents...
19.
Pluta P, Giza A, Kolenda M, Fendler W, Braun M, Chudobinski C, et al.
Arch Med Sci
. 2023 Sep;
19(5):1243-1251.
PMID: 37732037
Introduction: Although breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is infrequent, with less than 1000 noted cases worldwide, patients consenting for breast implant surgery should be aware of its risk....
20.
Bednarek R, Wojkowska D, Braun M, Watala C, Salifu M, Swiatkowska M, et al.
Cancer Cell Int
. 2023 Aug;
23(1):160.
PMID: 37563645
Background: The F11R/JAM-A cell adhesion protein was examined as the therapeutic target in triple negative breast cancer (TNBC) with the use of the peptide antagonist to F11R/JAM-A, that previously inhibited...